Warner

Lewis J W, Warner J, Einterz C M and Kliger D S 1987 Noise reduction in laser photolysis studies of photolabile samples using an optical multichannel analyzer Rev. Sol. Instrum. 58 945-9... 

Pood Red 14 [16423-68-0] 45430 erythrosine Warner Jenkinson Co. Hilton-Davis... 

K. Wark and C. F. Warner, Air Pollution Its Origin and Control, Dun-DoimeUey Publishing Corporation, New York, 1976. 

P. O. Warner, Analysis of Air Pollutants,John Wiley Sons, Inc., New York, 1976. 

B. F. Warner, joint symposium. The Scaling-Up of Chemical Plant and Processes, London, 1957, p. 44. 

Although controversy exists over the cholinergic involvement in AD dementia, as of 1993 the only AD therapy approved by the U.S. FDA was the cholinesterase inhibitor, tacrine [321-64-2] C 2H 4N2, sold as Cognex (Warner-Lambert). 

T. Warner, Proc. 71st Jinn. Meet. NutGrowers Soc. Oreg. Wash. C B.C. 71, 37 (1986). 

Aluminum Acetates" in ECT 1st ed. under "Aluminum Compounds," Vol. 1, pp. 626 —627, "Aluminum Formates" in ECT 1st ed. under "Aluminum Compounds," Vol. 1, pp. 630—632, by Benjamin Toubes, Victor Chemical Works, "Aluminum Acetate" in ECT 2nd ed. under "Aluminum Compounds," Vol. 2, pp. 11—13, by Albert Stewart, MaUinckrodt Chemical Works, "Aluminum Formate" in ECT 2nd ed. under "Aluminum Compounds," Vol. 2, pp. 14—17, by Benjamin Toubes, Victor Chemical Works, a Division of Stauffer Chemical Company, "Aluminum Carboxylates" in ECT 3rd ed. under "Aluminum Compounds," Vol. 2, pp. 202—209, by Glenn H. Warner, Union Carbide Corporation. 

G. Siskiud, "Agiug and the Immune System," iu H. R. Warner, ed.. Modem Biological Theories ofMging Raven Press, New York, 1987, pp. 235-242. 

W. C. Warner, Methods of Tdevulcanicyation, Rubber Chemistry and Technology, Rubber Reviews, Rubber Division, American Chemical Society, Inc., Washington,... 

S. Shindel and S. Ulrich, Report of Epidemiologic Study Warner Electric Brake eV Clutch Co., South Beloit, III, Jan. 1957 to July 1983, Ergotopology Investigative Mediciue for Industry, Milwaukee, Wis., Aug. 1984. 

Nicotrol, developed by Cygaus Corp. and to be marketed by Warner-Lambert, is the fourth nicotine transdermal system to be approved ia the Uoited States. It dehvers nicotine only duriag wakiag hours to mimic better the habits of smokers (109). la oae coatroUed study, ao statistical differeaces ia efficacy and good tolerabihty were observed for the wakiag and continuous regimen (112). 

---